These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8710500)

  • 1. Characterization of several kinds of dimer minizyme: simultaneous cleavage at two sites in HIV-1 tat mRNA by dimer minizymes.
    Kuwabara T; Amontov SV; Warashina M; Ohkawa J; Taira K
    Nucleic Acids Res; 1996 Jun; 24(12):2302-10. PubMed ID: 8710500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of tRNA-embedded dimeric minizymes.
    Kuwabara T; Warashina M; Nakayama A; Ohkawa J; Taira K
    Nucleic Acids Symp Ser; 1997; (37):307-8. PubMed ID: 9586122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dependence on Mg2+ ions of the activities of dimeric hammerhead minizymes.
    Amontov S; Nishikawa S; Taira K
    FEBS Lett; 1996 May; 386(2-3):99-102. PubMed ID: 8647298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic activities of hammerhead ribozymes with a triterpenoid linker instead of stem/loop II.
    Sugiyama H; Hatano K; Saito I; Amontov S; Taira K
    FEBS Lett; 1996 Sep; 392(3):215-9. PubMed ID: 8774847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of a catalytically active dimer by tRNA(Val)-driven short ribozymes.
    Kuwabara T; Warashina M; Orita M; Koseki S; Ohkawa J; Taira K
    Nat Biotechnol; 1998 Oct; 16(10):961-5. PubMed ID: 9788354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A minimised hammerhead ribozyme with activity against interleukin-2 in human cells.
    Sioud M; Opstad A; Hendry P; Lockett TJ; Jennings PA; McCall MJ
    Biochem Biophys Res Commun; 1997 Feb; 231(2):397-402. PubMed ID: 9070287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of minimised hammerhead ribozymes.
    Hendry P; McCall MJ; Santiago FS; Jennings PA
    Nucleic Acids Res; 1995 Oct; 23(19):3922-7. PubMed ID: 7479037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of an inaccessible site by the maxizyme with two independent binding arms: an alternative approach to the recruitment of RNA helicases.
    Kuwabara T; Warashina M; Taira K
    J Biochem; 2002 Jul; 132(1):149-55. PubMed ID: 12097172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins such as Tat and Rev.
    Yuyama N; Ohkawa J; Koguma T; Shirai M; Taira K
    Nucleic Acids Res; 1994 Nov; 22(23):5060-7. PubMed ID: 7800500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of structure in a long target RNA on ribozyme cleavage efficiency.
    Campbell TB; McDonald CK; Hagen M
    Nucleic Acids Res; 1997 Dec; 25(24):4985-93. PubMed ID: 9396806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cleavage of full-length beta APP mRNA by hammerhead ribozymes.
    Denman RB
    Nucleic Acids Res; 1993 Aug; 21(17):4119-25. PubMed ID: 8371986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
    Sun LQ; Wang L; Gerlach WL; Symonds G
    Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of HIV TAR RNA with RNA scissors.
    Wyszko E; Fuerste JP; Barciszewska M; Szymanski M; Adamiak R; Erdmann VA; Barciszewski J
    J Biochem; 1999 Aug; 126(2):326-32. PubMed ID: 10423525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific cleavage of the transactivation response site of human immunodeficiency virus RNA with a tat-based chemical nuclease.
    Jayasena SD; Johnston BH
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3526-30. PubMed ID: 1565648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribozyme targeting of HIV-1 LTR.
    Ventura M; Wang P; Franck N; Saragosti S
    Biochem Biophys Res Commun; 1994 Sep; 203(2):889-98. PubMed ID: 8093072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of site-specifically modified oligoribonucleotides for studies of the recognition of TAR RNA by HIV-1 tat protein and studies of hammerhead ribozymes.
    Slim G; Pritchard C; Biala E; Asseline U; Gait MJ
    Nucleic Acids Symp Ser; 1991; (24):55-8. PubMed ID: 1841380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using linkers to investigate the spatial separation of the conserved nucleotides A9 and G12 in the hammerhead ribozyme.
    Hendry P; Moghaddam MJ; McCall MJ; Jennings PA; Ebel S; Brown T
    Biochim Biophys Acta; 1994 Oct; 1219(2):405-12. PubMed ID: 7522573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.
    Naryshkin NA; Gait MJ; Ivanovskaya MG
    Biochemistry (Mosc); 1998 May; 63(5):489-503. PubMed ID: 9632883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Satellite cereal yellow dwarf virus-RPV (satRPV) RNA requires a douXble hammerhead for self-cleavage and an alternative structure for replication.
    Song SI; Silver SL; Aulik MA; Rasochova L; Mohan BR; Miller WA
    J Mol Biol; 1999 Nov; 293(4):781-93. PubMed ID: 10543967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of HIV-RNA targeted ribozymes transcribed from a 'shot-gun' type ribozyme-trimming plasmid.
    Ohkawa J; Yuyama N; Taira K
    Nucleic Acids Symp Ser; 1992; (27):15-6. PubMed ID: 1289797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.